Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time
- 1 September 1993
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 27 (1) , 125-127
- https://doi.org/10.1016/0360-3016(93)90429-y
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- High 10-Year Survival Rate in Patients With Early, Untreated Prostatic CancerJAMA, 1992
- Deferred Treatment in Clinically Localised Prostatic CarcinomaBritish Journal of Urology, 1992
- Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation TherapyJournal of Urology, 1991
- Cancer Control following Anatomical Radical Prostatectomy: An Interim ReportJournal of Urology, 1991
- Prostatc specific antigen as an indicator of response to radiotherapy in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated PatientsJournal of Urology, 1989
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987